Seriously that's stupid logic for the biotech sector , Most biotech companies have market caps that dont reflect revenue or lack of revenue.
For Somnomed its about growth expectations and market potential. Somnomed is the leader in its market and is operating in many countries and recently released an announcement regarding a recent report that compared cpap Vs oral appliance (SomnoDent) for mild,moderate,severe sleep apnea. SomnoDent was just as comparably successful as cpap. Now lets compare Som's $35m market cap to the 10Bplus cpap market valued companies.
http://www.asx.com.au/asxpdf/20130612/pdf/42gf7jv5222x16.pdf
Seriously that's stupid logic for the biotech sector , Most...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $95.08M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 29.0¢ | $7.157K | 24.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 3200 | 1 |
View Market Depth
| Last trade - 10.37am 15/11/2024 (20 minute delay) ? |
| SOM (ASX) Chart |
